Archivio delibere
Seduta del 21/04/2011
Delibera del 21 Aprile, n. 187 [file.pdf]
AUTORIZZAZIONE ALLO SVOLGIMENTO DELLO STUDIO CLINICO MK0653C-162,
DAL TITOLO: A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk Who are not Adequately Controlled with Atorvastatin 10 mg; A Comparison of the Efficacy and Safety of Switching to Coadministration Ezetimibe and Atorvastatin Versus Doubling the Dose of Atorvastatin or Switching to Rosuvastatin
SOGGETTO PROMOTORE:COVANCE CAPS Ltd (in nome e per conto di Merck Sharp & Dohme Corp 6 Roxborough Way)
AUTORIZZAZIONE ALLO SVOLGIMENTO DELLO STUDIO CLINICO MK0653C-162,
DAL TITOLO: A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk Who are not Adequately Controlled with Atorvastatin 10 mg; A Comparison of the Efficacy and Safety of Switching to Coadministration Ezetimibe and Atorvastatin Versus Doubling the Dose of Atorvastatin or Switching to Rosuvastatin
SOGGETTO PROMOTORE:COVANCE CAPS Ltd (in nome e per conto di Merck Sharp & Dohme Corp 6 Roxborough Way)
In pubblicazione dal: 21/04/2011